CG Oncology (CGON) Assets Average (2024 - 2026)

CG Oncology (CGON) has 3 years of Assets Average data on file, last reported at $963.4 million in Q1 2026.

• Quarterly Assets Average rose 29.93% year-over-year to $963.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $963.4 million (up 29.93% YoY) and the FY2025 annual result came in at $773.2 million, up 62.08% from the prior year.
• Assets Average climbed to $963.4 million in Q1 2026, from $760.8 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $963.4 million in Q1 2026 to a low of $389.2 million in Q1 2024.
• A 3-year average of $674.3 million and a median of $714.8 million in 2025 frame the typical range for Assets Average.
• The widest YoY moves for Assets Average: up 90.51% in 2025, down 16.39% in 2025.
• Tracing CGON's Assets Average over 3 years: stood at $653.6 million in 2024, then rose by 16.39% to $760.8 million in 2025, then advanced by 26.64% to $963.4 million in 2026.
• The last three Assets Average figures came in at $963.4 million (Q1 2026), $760.8 million (Q4 2025), and $715.7 million (Q3 2025), per Business Quant data.